Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 26, 2023

SELL
$95.53 - $114.62 $22,258 - $26,706
-233 Reduced 1.01%
22,782 $2.21 Million
Q2 2023

Aug 07, 2023

SELL
$100.78 - $112.29 $561,243 - $625,343
-5,569 Reduced 19.48%
23,015 $2.51 Million
Q1 2023

Apr 27, 2023

BUY
$96.86 - $114.01 $227,621 - $267,923
2,350 Added 8.96%
28,584 $2.89 Million
Q4 2022

Jan 18, 2023

SELL
$95.06 - $111.52 $389,460 - $456,897
-4,097 Reduced 13.51%
26,234 $2.88 Million
Q2 2022

Jul 13, 2022

SELL
$102.07 - $123.37 $377,454 - $456,222
-3,698 Reduced 10.87%
30,331 $3.3 Million
Q1 2022

Apr 26, 2022

SELL
$114.02 - $139.04 $456,080 - $556,160
-4,000 Reduced 10.52%
34,029 $4.03 Million
Q4 2021

Feb 07, 2022

BUY
$115.53 - $141.46 $462,120 - $565,840
4,000 Added 11.75%
38,029 $5.35 Million
Q2 2021

Aug 10, 2021

SELL
$105.79 - $124.53 $740,530 - $871,710
-7,000 Reduced 17.06%
34,029 $3.95 Million
Q1 2021

Apr 20, 2021

BUY
$108.84 - $128.23 $3.47 Million - $4.09 Million
31,919 Added 350.37%
41,029 $4.92 Million
Q3 2020

Oct 26, 2020

BUY
$91.64 - $111.29 $91,640 - $111,290
1,000 Added 12.33%
9,110 $991,000
Q2 2020

Jul 17, 2020

SELL
$76.57 - $98.0 $76,570 - $98,000
-1,000 Reduced 10.98%
8,110 $741,000
Q1 2020

Apr 30, 2020

BUY
$62.82 - $91.86 $62,820 - $91,860
1,000 Added 12.33%
9,110 $719,000
Q3 2019

Oct 22, 2019

SELL
$81.84 - $88.74 $66,044 - $71,613
-807 Reduced 9.05%
8,110 $679,000
Q1 2019

Apr 11, 2019

BUY
$66.22 - $80.06 $12,979 - $15,691
196 Added 2.25%
8,917 $713,000
Q4 2018

Jan 22, 2019

BUY
$65.56 - $74.27 $571,748 - $647,708
8,721 New
8,721 $631,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $208B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Handelsinvest Investeringsforvaltning Portfolio

Follow Handelsinvest Investeringsforvaltning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Handelsinvest Investeringsforvaltning, based on Form 13F filings with the SEC.

News

Stay updated on Handelsinvest Investeringsforvaltning with notifications on news.